Tskhovrebov S V, Poplavskaia L M
Anesteziol Reanimatol. 1996 Jan-Feb(1):58-60.
The authors assessed the efficacy and safety of intravenous lomir used to treat arterial hypertension in 10 coronary patients early after aortocoronary shunting. The following parameters were monitored: systolic, diastolic, and mean arterial pressure, ECG, pressure in the pulmonary artery, blood gases, and minute volume obtained by thermodilution. Intravenous lomir was found to be a highly effective hypotensive agent in patients in the early periods after aortocoronary shunting, well tolerated by the patients, the infusions being easy to monitor and involving virtually no side effects. Lomir improved the coronary bloodstream, virtually did not influence the heart rate, atrioventricular conduction, and pumping function of the heart.
作者评估了静脉注射洛米尔在10例主动脉冠状动脉分流术后早期冠心病患者中治疗动脉高血压的疗效和安全性。监测了以下参数：收缩压、舒张压和平均动脉压、心电图、肺动脉压力、血气以及通过热稀释法测得的每分容积。结果发现，静脉注射洛米尔在主动脉冠状动脉分流术后早期对患者是一种高效的降压药物，患者耐受性良好，输液易于监测且几乎无副作用。洛米尔改善了冠状动脉血流，实际上不影响心率、房室传导及心脏泵血功能。
